Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130689
Status:
COMPLETED
Last Update Posted:
2015-05-14
First Post:
2005-08-15
Brief Title:
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-07
Start Date Type:
None
Primary Completion Date:
2010-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-09
Completion Date Type:
ACTUAL
First Submit Date:
2005-08-15
First Submit QC Date:
August 15 2005
Study First Post Date:
2005-08-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-05-14
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-12
Last Update Post Date:
2015-05-14
Last Update Post Date Type:
ESTIMATED